Sign in
8-K

Current Report

Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-24-076339

Material agreement

  • Item 1.01 Entry into a material definitive agreement

From the SEC's structured data for this filing

Loading amlx-20240621.htm…